Beyond foreign-body-induced carcinogenesis: Impact of reactive oxygen species derived from inflammatory cells in tumorigenic conversion and tumor progression

International Journal of Cancer

Volumn 121, Issue 11, 2007, Pages 2364-2372

  Okada, Futoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Carcinogenesis; Foreign body; Inflammation; ROS; Tumor progression

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALUMINUM OXIDE; AMOSITE; ASBESTOS FIBER; BETA2 INTEGRIN; CADMIUM; CHROMIUM; CHRYSOTILE; COBALT; CROCIDOLITE; EPIDERMAL GROWTH FACTOR; GELATINASE B; GLYCOPROTEIN GP 91; INTERSTITIAL COLLAGENASE; LEAD; NICKEL; NICKEL COMPLEX; POLY(METHYL METHACRYLATE); POLYETHYLENE; POLYURETHAN; POLYVINYLCHLORIDE; RAC1 PROTEIN; RAC2 PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THYMOSIN BETA4; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ANGIOSARCOMA; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; FIBROSARCOMA; FOREIGN BODY; GASTROINTESTINAL CARCINOMA; GENOTOXICITY; HUMAN; INFLAMMATORY CELL; LEIOMYOSARCOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MESOTHELIOMA; METASTASIS; MYXOSARCOMA; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; STROMA CELL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ASBESTOS; CICATRIX; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EQUIPMENT AND SUPPLIES; FOREIGN BODIES; HUMANS; INFLAMMATION; METALS; MINERAL FIBERS; NEOPLASMS; REACTIVE OXYGEN SPECIES; WOUND HEALING; WOUNDS AND INJURIES;

EID: 35648972647     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23125     Document Type: Review

References (112)

1. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
2. World Health Organization and International Union Against Cancer. Global action against cancer-updated version. Geneva: WHO, 2005.12.
3. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
4. Boone CW. Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads. Science 1975;188:68-70.
5. Boone CW, Jacobs JB. Sarcomas routinely produced from putatively nontumorigenic Balb/3T3 and C3H/10T1/2 cells by subcutaneous inoculation attached to plastic platelets. J Supramol Struct 1976;5:131-7.
6. Boone CW, Takeichi N, Paranjpe M, Gilden R. Vasoformative sarcomas arising from BALB/3T3 cells attached to solid substrates. Cancer Res 1976;36:1626-33.
7. Takeichi N. Spontaneous transformation of in vitro normal cells. Hokkaido Igaku Zasshi 1978;52:353-4.
8. Boone CW, Takeichi N, Eaton SD, Paranjpe M. "Sontaneous" neoplastic transformation in vitro: a form of foreign body (smooth surface) tumorigenesis. Science 1979;204:177-9.
9. Boone CW, Vembu D, White BJ, Takeichi N, Paranjpe M. Karyotype, antigenic, and kidney-invasive properties of cell lines from fibrosarcomas arising in C3H/10T1/2 cells implanted subcutaneously attached to plastic plates. Cancer Res 1979;39:2172-8.
10. Brand KG. In: Symington T, Carter RL, eds. Scientific foundations of oncology. London: Wm Heineman Med Book Ltd, 1976.490-95.
11. Brand KG, Brand I. Risk assessment of carcinogenesis at implantation sites. Plast Reconstr Surg 1980;66:591-5.
12. Brand KG. In: Becker FF, ed. Cancer: a comprehensive treatise, 2nd edn., vol. 1. New York: Plenum Press, 1982.661-92.
13. Borm PJ, Driscoll K. Particles, inflammation and respiratory tract carcinogenesis. Toxicol Lett 1996;88:109-13.
14. Belinsky SA, Snow SS, Nikula KJ, Finch GL, Tellez CS, Palmisano WA. Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis 2002;23:335-9.
15. Nettesheim P, Topping DC, Jamasbi R. Host and environmental factors enhancing carcinogenesis in the respiratory tract. Annu Rev Pharmacol Toxicol 1981;21:133-63.
16. Pott P. Chirurgical observations relative to the cataract, the polypus of the nose, cancer of the scrotum, different kinds of ruptures, and the modification of the toes and feet. London Hawes 1775;1-208.
17. Falk HL, Steiner PE. The identification of aromatic polycyclic hydrocarbons in carbon blacks. Cancer Res 1952;12:30-9.
18. Sorahan T, Harrington JM. A "lugged" analysis of lung cancer risks in UK carbon black production workers, 1951-2004. Am J Ind Med 2007;50:555-64.
19. Nickell-Brady C, Hahn FF, Finch GL, Belinsky SA. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 1994;15:257-62.
20. Chen H-W, Su S-F, Chien C-T, Lin W-H, Yu S-L, Chou C-C, Chen JJW. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB J 2006;20:2393-5.
21. Maeda M, Hino O. Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers. Pathol Int 2006;56:649-54.
22. Stanton MF. Fiber carcinogenesis: is asbestos the only hazard? J Natl Cancer Inst 1974;52:633-4.
23. Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y. Asbestos-related lung cancer and mesothelioma in Japan. Ind Health 2001;39:65-74.
24. Nizze H. Exposure to asbestos and the genesis of pleural plaques and neoplasia. Arch Pathol 1973;95:213-4.
25. Selokoff IJ, Churg J, Hammond EC. Asbestos exposure and neoplasia. JAMA 1964;188:22-6.
26. Roe FJ, Carter RL, Walters MA, Harington JS. The pathological effects of subcutaneous injections of asbestos fibres in mice: migration of fibres to submesothelial tissues and induction of mesotheliomata. Int J Cancer 1967;2:628-38.
27. Wagner JC. Experimental production of mesothelial tumours of the pleura by implantation of dusts in laboratory animals. Nature 1962;196:180-1.
28. Rigdon RH. Tissue reaction to foreign materials. CRC Crit Rev Toxicol 1975;3:435-76.
29. Steenland K, Stayner L. Silica, asbestos, man-made mineral fibers, and cancer. Cancer Causes Control 1997;8:491-503.
30. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002;16:217-32.
31. Weitzman SA, Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 1984;228:373-6.
32. Maples KR, Johnson NF. Fiber-induced hydroxyl radical formation: correlation with mesothelioma induction in rats and humans. Carcinogenesis 1992;13:2035-9.
33. Fung H, Kow YW, van Houten B, Mossman BT. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 1997;18:825-32.
34. Thomas G, Ando T, Verma K, Kagan E. Asbestos fibers and interferon-gamma up-regulate nitric oxide production in rat alveolar macrophages. Am J Respir Cell Mol Biol 1996;11:707-15.
35. Klaus U, Claudia S, Josef A. Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res 2002;62:99-104.
36. Robinson BWS, Richard A, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;353:1591-603.
37. Kawanishi S, Hiraku Y, Murata M, Oikawa S. The role of metals in site-specific DNA damage with reference to carcinogenesis. Free Radic Biol Med 2002;32:822-32.
38. Kasprzak KS. Possible role of oxidative damage in metal-induced carcinogenesis. Cancer Invest 1995;13:411-30.
39. Kawanishi S, Inoue S, Oikawa S, Yamashita N, Toyokuni S, Kawanishi M, Nishino K. Oxidative DNA damage in cultured cells and rat lungs by carcinogenic nickel compounds. Free Radic Biol Med 2001;31:108-16.
40. Hoopes JE, Edgerton MT, Jr, Shelley W. Organic synthetics for augmentation mammaplasty: their relation to breast cancer. Plast Reconstr Surg 1967;39:263-70.
41. Villeneuve PJ, Holowaty EJ, Brisson J, Xie L, Ugnat AM, Latulippe L, Mao Y. Mortality among Canadian women with cosmetic breast implants. Am J Epidemiol 2006;164:334-41.
42. Clark CP, Peters GN, O'Brien KM. Cancer in the augmented breast. Diagnosis and prognosis. Cancer 1993;72:2170-4.
43. Skinner KA, Silberman H, Dougherty W, Gamagami P, Waisman J, Sposto R, Silverstein MJ. Breast cancer after augmentation mammoplasty. Ann Surg Oncol 2001;8:138-44.
44. Le GM, O'Malley CD, Glaser SL, Lynch CF, Stanford JL, Keegan TH, West DW. Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival. Breast Cancer Res 2005;7:R184-93.
45. Case CP, Langkamer VG, Howell RT, Webb J, Standen G, Palmer M, Kemp A, Learmonth ID. Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop Relat Res 1996;329:S269-79.
46. Friedrich G. Periphere Lungenkrebse auf dem Boden pleuranaher Narben. Virchows Arch Pathol Anat 1939;304:230-47.
47. Rössle R. Die Narbenkrebse der Lungen. Schweizerische Medizinische Wochenschrift 1943;39:1200-3.
48. Qin Z, Kim HJ, Hemme J, Blankenstein T. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction. J Exp Med 2002;195:1479-90.
49. Kirkpatrick CJ, Alves A, Köhler H, Kriegsmann J, Bittinger F, Otto M, Williams DF, Eloy R. Biomaterial-induced sarcoma: a novel model to study preneoplastic change. Am J Pathol 2000;156:1455-67.
50. Brand KG, Buoen LC, Brand I. Foreign-body tumorigenesis induced by glass, and smooth, and rough plastic: comparative study of preneoplastic events. J Natl Cancer Inst 1975;55:319-22.
51. Brand KG, Buoen LC, Brand I. Multiphasic incidence of foreign body-induced sarcomas. Cancer Res 1976;36:3681-3.
52. Shimosato Y, Suzuki A, Hashimoto T, Nishiwaki Y, Kodama T, Yoneyama T, Kameya T. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 1980;4:365-73.
53. Moizhess TG, Vasiliev JM. Early and late stages of foreign-body carcinogenesis can be induced by implants of different shapes. Int J Cancer 1989;44:449-53.
54. Dolberg DS, Hollingsworth R, Hertle M, Bissell MJ. Wounding and its role in RSV-mediated tumor formation. Science 1985;230:676-8.
55. Weiss L. Some effects of mechanical trauma on the development of primary cancers and their metastases. J Forensic Sci 1990;35:614-27.
56. Kotin P, Kahler JE. Possible role of trauma as a cocarcinogen; case report on an oil worker. Cancer 1953;6:266-8.
57. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976;37:2861-5.
58. Domellof L, Janunger KG. The risk for gastric carcinoma after partial gastrectomy. Am J Surg 1977;134:581-4.
59. van den Hooff A. Stromal involvement in malignant growth. Adv Cancer Res 1988;50:159-96.
60. Madri JA, Carter D. Scar cancers of the lung: origin and significance. Hum Pathol 1984;15:625-31.
61. Turner FC. Sarcomas at sites of subcutaneously implanted Bakelite disks in rats. J Natl Cancer Inst 1941;2:81-3.
62. http://acswebcontent.acs.org/landmarks/newproducts_t.html#bakelite
63. Brand KG, Buoen LC, Brand I. Foreign-body tumorigenesis by vinyl chloride vinyl acetate copolymer: no evidence for chemical carcinogenesis. J Natl Cancer Inst 1975;54:1259-62.
64. Brand I, Buoen LC, Brand KG. Foreign-body tumors of mice: strain and sex differences in latency and incidence. J Natl Cancer Inst 1977;58:1443-7.
65. Oppenheimer BS, Oppenheimer ET, Danishefsky I, Stout AP. Carcinogenic effect of metals in rodents. Cancer Res 1956;16:439-41.
66. Bischoff F, Bryson G. Carcinogenesis through solid state surfaces. Prog Exp Tumor Res 1964;14:85-133.
67. Furst A. Bioassay of metals for carcinogenesis: whole animals. Environ Health Perspect 1981;40:83-91.
68. Vasiliev JM. Cell microenvironment and carcinogenesis in vivo and in vitro. IARC Sci Publ 1983;51:247-56.
69. Bischoff F, Bryson G. Carcinogenesis through solid state surfaces. Prog Exp Tumor Res 1964;14:85-133.
70. James SJ, Pogribna M, Miller BJ, Bolon B, Muskjelishvili L. Characterization of cellular response to silicone implants in rats: implications for foreign-body carcinogenesis. Biomaterials 1997;18:667-75.
71. Tazawa H, Tatemichi M, Sawa T, Gilibert I, Ma N, Hiraku Y, Donehower LA, Ohgaki H, Kawanishi S, Ohshima H. Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/- mice. Carcinogenesis 2007;28:191-8.
72. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333-7.
73. Tatemichi M, Sawa T, Gilibert I, Tazawa H, Katoh T, Ohshima H. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter. Cancer Lett 2005;217:197-202.
74. Ellie E, Loiseau H, Lafond F, Arsaut J, Demotes-Mainard J. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. Neuroreport 1995;7:294-6.
75. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-4.
76. Dogan AU, Baris YI, Emri S, Steele I, Elmishad AG, Carbone M. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006;66:5063-8.
77. Heppner GH, Dorcey L. In: Heppner GH, Fulton AM, eds. Macrophages and cancer. Boca Raton, Florida: CRC Press, 1988.197-208.
78. Kobayashi H, Sendo F, Shirai T, Kaji H, Kodama T. Modification in growth of transplantable rat tumors exposed to Friend virus. J Natl Cancer Inst 1969;42:413-9.
79. d). Cancer Res 1987;47:3136-40.
80. Ishikawa M, Okada F, Hamada J-I, Hosokawa M, Kobayashi H. Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine. Int J Cancer 1987;39:338-42.
81. Hamada J, Takeichi N, Okada F, Ren J, Li X, Hosokawa M, Kobayashi H. Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn J Cancer Res 1992;83:483-90.
82. Cristofanilli M, Buzdar AU, Hortobagyi GN. Update on the management of inflammatory breast cancer. Oncologist 2003;8:141-8.
83. Li X, Nagayasu H, Hamada J-I, Hosokawa M, Takeichi N. Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-β. Jpn J Cancer Res 1993;84:1145-9.
84. Hamada J, Nakata D, Nakae D, Kobayashi Y, Akai H, Konishi Y, Okada F, Shibata T, Hosokawa M, Moriuchi T. Increased oxidative DNA damage in mammary tumor cells by continuous epidermal growth factor stimulation. J Natl Cancer Inst 2001;93:214-9.
85. Nagayasu H, Hamada J, Nakata D, Shibata T, Kobayashi M, Hosokawa M, Takeichi N. Reversible and irreversible tumor progression of a weakly malignant rat mammary carcinoma cell line by in vitro exposure to epidermal growth factor. Int J Oncol 1998;12:197-202.
86. 2. Cancer Immunol Immunother 1990;31:358-64.
87. Okada F, Hosokawa M, Hamada J, Hasegawa J, Mizutani M, Takeichi N, Kobayashi H. Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates. Jpn J Cancer Res 1993;84:1230-6.
88. Okada F, Hosokawa M, Hamada J-I, Hasegawa J, Kato M, Mizutani M, Ren J, Takeichi N, Kobayashi H. Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). Br J Cancer 1992;66:635-9.
89. Okada F, Fujii J. Molecular mechanisms of inflammation-induced carcinogenesis. J Clin Biochem Nutr 2006;39:103-13.
90. Marx J. Biomedicine. Thymosins: clinical promise after a decades-long search. Science 2007;316:682-3.
91. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H, Hosokawa M. Thymosin β4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 2002;160:869-82.
92. Habelhah H, Okada F, Kobayashi M, Nakai K, Choi S, Hamada J, Moriuchi T, Kaya M, Yoshida K, Fujinaga K, Hosokawa M. Increased E1AF expression in mouse fibrosarcoma promotes metastasis through induction of MT1-MMP expression. Oncogene 1999;18:1771-6.
93. Okada F, Tazawa H, Kobayashi T, Kobayashi M, Hosokawa M. Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression. Nitric Oxide 2006;14:122-9.
94. Tazawa H, Okada F, Kobayashi T, Tada M, Mori Y, Une Y, Sendo F, Kobayashi M, Hosokawa M. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: Implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 2003;163:2221-32.
95. Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 2006;103:12493-8.
96. Okada F, Nakai K, Kobayashi T, Shibata T, Tagami S, Kawakami Y, Kitazawa T, Kominami R, Yoshimura S, Suzuki K, Taniguchi N, Inanami O, et al. Inflammatory-cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells. Br J Cancer 1999;79:377-85.
97. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-76.
98. Okada F, Kobayashi M, Tanaka H, Kobayashi T, Tazawa H, Iuchi Y, Onuma K, Hosokawa M, Dinauer MC, Hunt NH. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am J Pathol 2006;169:294-302.
99. Yoshida N, Granger DN, Evans DJ, Evans DG, Graham DY, Anderson DC, Wolf RE, Kvietys PR. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993;105:1431-40.
100. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev. 1993;2:537-44.
101. Levin B. Ulcerative colitis and colon cancer: biology and surveillance. J Cell Biochem Suppl 1992;16G:47-50.
102. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994;35:950-4.
103. Kawaguchi T, Miyaki M, Masui T, Watanabe M, Ohta H, Maruyama M, Utakoji T, Kitagawa T. Establishment and characterization of epithelial cell line with quasi-normal chromosomes from a tubular adenoma of a familial polyposis coli patient. Jpn J Cancer Res 1991;82:138-41.
104. Okada F, Kawaguchi T, Habelhah H, Kobayashi T, Tazawa H, Takeichi N, Kitagawa T, Hosokawa M. Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice. Lab Invest 2000;80:1617-28.
105. Sanford KS, Boone CW, Merwin RM, Jones GM, Garrison CU. The plate-implant as a bioassay for the neoplastic potential of cultured cells. Int J Cancer 1980;25:509-16.
106. Tatemichi M, Ogura T, Ishii Y, Esumi H. Role of inducible nitric oxide synthase activity in inflammation related carcinogenesis. Nitric Oxide 2002;6:473-4.
107. Fukuda T, Hirayama Y, Mitani H, Maeda H, Tsutsumi M, Konishi Y, Hino O. Generation of metastatic variants of Eker renal carcinoma cell lines for experimental investigation of renal cancer metastasis. Jpn J Cancer Res 1998;89:1104-8.
108. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
109. Habelhah H, Okada F, Nakai K, Choi SK, Hamada J, Kobayashi M, Hosokawa M. Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon α, tumor necrosis factor α and transforming growth factor β in Mn-SOD induction by polysaccharide K. Cancer Immunol Immunother 1998;46:338-44.
110. Okada F, Shionoya H, Kobayashi M, Kobayashi T, Tazawa H, Onuma K, Iuchi Y, Matsubara N, Ijichi T, Dugas B, Hosokawa M. Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase. Br J Cancer 2006;94:854-62.
111. Kawanishi S, Hiraku Y, Pinlaor S, Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Bio Chem 2006;387:365-72.
112. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.